ey0020.8-11 | New Mechanisms | ESPEYB20
SS Leung
, DJ Borg
, DA McCarthy
, TE Boursalian
, J Cracraft
, A Zhuang
, AK Fotheringham
, N Flemming
, T Watkins
, JJ Miles
, PH Groop
, JL Scheijen
, CG Schalkwijk
, RJ Steptoe
, KJ Radford
, M Knip
, JM Forbes
Brief summary: using a murine model of diabetes and ex vivo experiments in human T-cell cultures, this study showed that short-term administration of an antagonist to the receptor for advanced glycation end products (sRAGE) modulates functional T regulatory cells (Treg) expansion and thus prevents diabetes.This study provides further support for a role of the advanced glycation end-product (AGEs)-AGE receptor (RAGE) pathways in the pathogenesis ...